Rheumatoid Arthritis
Conditions
Brief summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. This data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future rheumatoid arthritis patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient has been diagnosed with rheumatoid arthritis * Patient has self-identified as planning to enroll in an interventional clinical trial * Patient is 18 years old
Exclusion criteria
* ECOG score of 4 * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient decides to enroll in clinical trial | 3 Months |
| Patient remains in clinical trial to completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed